Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of MDMA-assisted therapy for PTSD on self-experience.
van der Kolk BA, Wang JB, Yehuda R, Bedrosian L, Coker AR, Harrison C, Mithoefer M, Yazar-Klosinki B, Emerson A, Doblin R. van der Kolk BA, et al. Among authors: doblin r. PLoS One. 2024 Jan 10;19(1):e0295926. doi: 10.1371/journal.pone.0295926. eCollection 2024. PLoS One. 2024. PMID: 38198456 Free PMC article. Clinical Trial.
MDMA ("ecstasy") and neurotoxicity.
Mithoefer M, Jerome L, Doblin R. Mithoefer M, et al. Among authors: doblin r. Science. 2003 Jun 6;300(5625):1504-5; author reply 1504-5. doi: 10.1126/science.300.5625.1504. Science. 2003. PMID: 12791964 No abstract available.
Response to: Parrott AC, Buchanan T, Heffernan TM, Scholey A, Ling J, Rodgers J (2003) Parkinson's disorder, psychomotor problems and dopaminergic neurotoxicity in recreational ecstasy/MDMA users. Psychopharmacology 167(4):449-450.
Sumnall HR, Jerome L, Doblin R, Mithoefer MC. Sumnall HR, et al. Among authors: doblin r. Psychopharmacology (Berl). 2004 Jan;171(2):229-30. doi: 10.1007/s00213-003-1599-3. Epub 2003 Nov 21. Psychopharmacology (Berl). 2004. PMID: 14634709 No abstract available.
Ecstasy use-Parkinson's disease link tenuous.
Jerome L, Doblin R, Mithoefer M. Jerome L, et al. Among authors: doblin r. Mov Disord. 2004 Nov;19(11):1386. doi: 10.1002/mds.20223. Mov Disord. 2004. PMID: 15389978 No abstract available.
The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study.
Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Doblin R. Mithoefer MC, et al. Among authors: doblin r. J Psychopharmacol. 2011 Apr;25(4):439-52. doi: 10.1177/0269881110378371. Epub 2010 Jul 19. J Psychopharmacol. 2011. PMID: 20643699 Free PMC article. Clinical Trial.
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.
Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Martin SF, Yazar-Klosinski B, Michel Y, Brewerton TD, Doblin R. Mithoefer MC, et al. Among authors: doblin r. J Psychopharmacol. 2013 Jan;27(1):28-39. doi: 10.1177/0269881112456611. Epub 2012 Nov 20. J Psychopharmacol. 2013. PMID: 23172889 Free PMC article. Clinical Trial.
49 results